Definition, Diagnostic Criteria & Classification

Question	Answer
1. Define Nephrotic Syndrome in children.	Nephrotic syndrome is a clinical and biochemical syndrome characterized by the classic tetrad of: 1) Heavy (nephrotic-range) proteinuria: Urine protein $\ge 3+$ or $4+$, urine protein excretion $>40\text{ mg/m}^2/\text{hour}$ ($>50\text{ mg/kg/day}$), or spot urine protein-to-creatinine ratio (UPCR) $>2.0\text{ mg/mg}$. 2) Hypoalbuminemia: Serum albumin $<2.5\text{ g/dL}$ (often $<2.0\text{ g/dL}$). 3) Generalized edema / anasarca: Matutinal periorbital puffiness progressing to ascites and dependent edema. 4) Hyperlipidemia: Serum cholesterol $>200\text{ mg/dL}$ with elevated LDL and triglycerides.
2. How is Nephrotic Syndrome classified based on response to corticosteroids?	According to IPNA 2023 / ISPN guidelines: - Steroid-Sensitive Nephrotic Syndrome (SSNS): Complete remission achieved within 4 weeks of standard-dose daily prednisolone ($60\text{ mg/m}^2/\text{day}$ or $2\text{ mg/kg/day}$). - Steroid-Resistant Nephrotic Syndrome (SRNS): Failure to achieve complete remission despite 4–6 weeks of daily prednisolone at standard dose. - Infrequent Relapser: $<2$ relapses in the first 6 months, or $<4$ relapses in any 12-month period. - Frequently Relapsing Nephrotic Syndrome (FRNS): $\ge 2$ relapses within 6 months of initial response, or $\ge 4$ relapses in any 12-month period. - Steroid-Dependent Nephrotic Syndrome (SDNS): Two consecutive relapses occurring during steroid therapy (on alternate days) or within 14 days of its discontinuation.
3. What is the modern definition of Complete Remission vs Relapse?	- Complete Remission: Urine protein nil or trace by dipstick (or UPCR $<0.2\text{ mg/mg}$) for 3 consecutive days. - Relapse: Urine protein $\ge 3+$ or $4+$ by dipstick (or UPCR $>2.0\text{ mg/mg}$) for 3 consecutive days, having previously achieved complete remission. - Partial Remission: Urine protein $1+$ to $2+$ with serum albumin $\ge 3.0\text{ g/dL}$.
4. What are the indications for Renal Biopsy in childhood Nephrotic Syndrome?	At Onset (Prior to Steroid Therapy): 1) Age of onset $<1\text{ year}$ (congenital/infantile nephrotic syndrome) or $>12\text{ years}$ (high incidence of non-MCD: membranous, MPGN, lupus). 2) Persistent macroscopic hematuria or significant microscopic hematuria with RBC casts. 3) Persistent sustained hypertension. 4) Persistent renal failure (elevated creatinine not attributable to intravascular volume depletion). 5) Low serum complement C3/C4 levels. 6) Extrarenal systemic signs suggestive of secondary GN (rash, purpura, arthritis). Post-Onset / During Course: 1) Steroid-Resistant Nephrotic Syndrome (SRNS) prior to starting calcineurin inhibitors. 2) Frequent relapses or steroid dependency before initiating Calcineurin Inhibitors (to assess baseline tubulointerstitial chronicity). 3) Unexplained deterioration in renal function while on CNIs.
5. VIVA TRAP: Why does hyperlipidemia occur in Nephrotic Syndrome? Is it due to dietary excess?	Absolutely NOT due to dietary excess. Hyperlipidemia is driven by two distinct hepatic mechanisms triggered by severe hypoalbuminemia: 1) Increased Hepatic Lipoprotein Synthesis: Reduced plasma oncotic pressure and low albumin stimulate generalized, non-specific hepatic protein and lipoprotein synthesis, markedly upregulating VLDL and LDL production. 2) Impaired Lipoprotein Clearance: Urinary loss of key regulatory cofactors, specifically Lipoprotein Lipase (LPL) activator Apolipoprotein C-II, as well as loss of Heparan Sulfate Proteoglycans, halts peripheral lipolysis and catabolism of circulating triglycerides and LDL.

Pathophysiology & Complications

Question	Answer
6. Explain the mechanism of proteinuria in Minimal Change Disease (MCD).	The glomerular filtration barrier consists of fenestrated endothelium, glomerular basement membrane (GBM), and podocyte foot processes with slit diaphragms. In MCD, cell-mediated immune dysregulation leads to production of circulating permeability factors (e.g., Angiopoietin-like 4, cytokine imbalance, or anti-nephrin autoantibodies). This causes: 1) Loss of Negative Charge Barrier: Depletion of negatively charged heparan sulfate proteoglycans in the GBM allows negatively charged albumin ($69\text{ kDa}$) to filter freely (charge-selective proteinuria). 2) Podocyte Effacement: Extensive podocyte foot process effacement and slit diaphragm disruption (loss of nephrin and podocin integrity), resulting in massive selective albuminuria.
7. What are the life-threatening complications of childhood Nephrotic Syndrome?	1) Infections: Spontaneous Bacterial Peritonitis (SBP) caused predominantly by Streptococcus pneumoniae and E. coli, pneumococcal sepsis, cellulitis, and pneumonia (due to urinary loss of IgG and complement factors B and properdin, combined with steroid immunosuppression). 2) Thromboembolism: Deep vein thrombosis, renal vein thrombosis (RVT), and pulmonary embolism (due to urinary loss of Antithrombin III and protein C/S, elevated fibrinogen and factor VIII, thrombocytosis, and hemoconcentration). 3) Hypovolemic Shock / Intravascular Depletion: Severe abdominal pain, cold extremities, tachycardia, and oliguria despite gross edema ("hypovolemic crisis" in underfilled nephrotic state). 4) Acute Kidney Injury (AKI): Pre-renal azotemia from severe hypovolemia, tubular necrosis, or bilateral renal vein thrombosis.
8. VIVA TRAP: How do you clinically differentiate the "Underfilled" from the "Overfilled" Nephrotic child?	This differentiation dictates whether to give volume expansion (albumin) or loop diuretics: - Underfilled State (Hypovolemic): Characterized by severe hypoalbuminemia ($<1.5\text{ g/dL}$), tachycardia, cold clammy peripheries, delayed CRT ($>3\text{ s}$), postural hypotension, oliguria with high urinary specific gravity ($>1.025$), elevated hematocrit ($>45\%$, hemoconcentration), and elevated BUN:Creatinine ratio ($>20:1$). Diuretics alone will precipitate renal failure and shock; Albumin infusion is life-saving. - Overfilled State (Hypervolemic): Characterized by primary renal sodium retention (distal tubular epithelial sodium channel / ENaC activation driven by filtered plasminogen/plasmin), normal or elevated blood pressure, full bounding pulses, distended neck veins, and normal CRT. Responds promptly to loop diuretics (Furosemide) without requiring albumin.
9. What are the signs of Renal Vein Thrombosis (RVT) in a nephrotic child?	Classical triad: Sudden gross hematuria, sudden severe unilateral or bilateral flank pain, and rapidly enlarging palpable tender flank masses (kidneys), accompanied by acute deterioration in GFR and worsening thrombocytopenia (platelet consumption). Diagnosis confirmed by emergency Renal Doppler USG showing absent or reversed venous flow.

Guidelines & Management Protocols (IPNA 2023 / ISPN)

Question	Answer
10. Detail the IPNA 2023 standard corticosteroid regimen for the First Episode of Nephrotic Syndrome.	- Induction Phase: Oral Prednisolone at $60\text{ mg/m}^2/\text{day}$ OR $2.0\text{ mg/kg/day}$ (maximum $60\text{ mg/day}$) given as a single morning dose for 4 to 6 weeks (or continued until complete remission is achieved for at least 3 consecutive days, up to a maximum of 6 weeks). - Maintenance Phase: Follow with oral Prednisolone at $40\text{ mg/m}^2$ OR $1.5\text{ mg/kg}$ on alternate days (maximum $40\text{ mg}$) as a single morning dose for 4 to 6 weeks. - Tapering: Gradually taper alternate-day dose by $0.25-0.5\text{ mg/kg}$ every 2 weeks over the subsequent 4–6 weeks, then discontinue. Total duration of initial steroid therapy: 12 to 16 weeks.
11. What is the protocol for managing an Infrequent Relapse?	- Administer oral Prednisolone at $60\text{ mg/m}^2/\text{day}$ ($2\text{ mg/kg/day}$, max 60 mg) daily until urine protein is nil or trace for 3 consecutive days (complete remission). - Follow immediately with oral Prednisolone at $40\text{ mg/m}^2$ ($1.5\text{ mg/kg}$, max 40 mg) on alternate days for 4 weeks. - Discontinue or rapidly taper over 2–4 weeks; prolonged tapering is not required for infrequent relapses.
12. What are the second-line steroid-sparing agents used in Frequently Relapsing (FRNS) and Steroid-Dependent (SDNS) cases?	When steroid threshold causes cushingoid toxicity, short stature, or osteoporosis, add a steroid-sparing agent: 1) Levamisole: $2.0-2.5\text{ mg/kg}$ on alternate days for 12–24 months (immunomodulator, low toxicity; monitor CBC for neutropenia). 2) Cyclophosphamide: Oral $2.0\text{ mg/kg/day}$ for 8–12 weeks (cumulative dose $<168\text{ mg/kg}$; risk of hemorrhagic cystitis, gonadal toxicity, alopecia). 3) Mycophenolate Mofetil (MMF): $800-1200\text{ mg/m}^2/\text{day}$ divided bid for 1–2 years (excellent safety profile; monitor for leukopenia and GI upset). 4) Calcineurin Inhibitors (CNIs): Tacrolimus ($0.1-0.15\text{ mg/kg/day}$ target trough level $4-8\text{ ng/mL}$) or Cyclosporine ($4-5\text{ mg/kg/day}$ target trough $100-150\text{ ng/mL}$); highly effective but nephrotoxic (requires serial GFR and trough level monitoring). 5) Rituximab (Anti-CD20 monoclonal antibody): 1–2 doses of $375\text{ mg/m}^2$ IV; reserved for severe refractory SDNS/FRNS dependent on high-dose steroids and CNIs.
13. VIVA TRAP: When and how should 20% Human Albumin be administered in Nephrotic Syndrome?	Indications are STRICT: 1) Severe symptomatic hypovolemia / shock (cold peripheries, CRT $>3\text{ s}$, hypotension). 2) Disabling, massive anasarca with scrotal/labial edema threatening skin breakdown or severe respiratory compromise from massive ascites. 3) Severe, refractory diuretic resistance. Protocol: Infuse 20% Albumin at $0.5-1.0\text{ g/kg}$ IV over 2 to 4 hours, followed by IV Furosemide at $1-2\text{ mg/kg}$ administered mid-infusion or at the end of the infusion. VIVA TRAP Warning: Giving albumin without furosemide can precipitate sudden intravascular volume overload and fatal acute pulmonary edema!

VIVA TRAPs & Counter-Questions

Question

Answer

14. VIVA TRAP: Can you administer live vaccines (MMR, Varicella) to a child on prednisolone for Nephrotic Syndrome?

NO. Live vaccines are strictly contraindicated while the child is on high-dose immunosuppressive corticosteroid therapy (prednisolone $\ge 2\text{ mg/kg/day}$ or $\ge 20\text{ mg/day}$ for $>14\text{ days}$).
Live vaccines can only be administered when the child has achieved complete remission and prednisolone has been tapered to low-dose alternate-day therapy ($<0.5\text{ mg/kg}$ on alternate days) or discontinued for at least 4 weeks.
Counter-Question: What vaccine MUST be given? Pneumococcal Polysaccharide Vaccine (PPSV23) and annual inactivated Influenza vaccine.

15. Counter-Question Chain: "If a 4-year-old nephrotic child on daily prednisolone is exposed to Chickenpox (Varicella), what is your immediate step?"

1) Step 1: Assess immunity (prior history of chickenpox or 2 doses of varicella vaccine).
2) Step 2: If non-immune and currently on high-dose steroids: Administer Varicella Zoster Immunoglobulin (VZIG) at $125\text{ Units}/10\text{ kg}$ IM (or IVIG $400\text{ mg/kg}$) within 96 hours (up to 10 days) of exposure.
3) Step 3: If VZIG is unavailable or $>10\text{ days}$ have elapsed: Start prophylactic oral Acyclovir ($20\text{ mg/kg/dose}$ qid, max 800 mg) starting 7 days after exposure and continuing for 7 days.
4) Step 4: If the child develops vesicular rash: Immediately admit for Intravenous Acyclovir ($500\text{ mg/m}^2$ or $10-15\text{ mg/kg}$ q8h) and reduce prednisolone to physiologic replacement dose ($10-12\text{ mg/m}^2/\text{day}$) to prevent visceral dissemination while avoiding acute adrenal crisis.